Chelsea Hospital Expands Advanced Imaging Services with New PET/CT, Mobile MRI
November 16, 2026
FOR IMMEDIATE RELEASE
Media Contact: Von Lozon
Pager: (248) 725-2400
von.lozon@trinity-health.org
CHELSEA, Mich. (Nov. 16, 2026) – Chelsea Hospital announced the expansion of advanced diagnostic imaging with its acquisition of on-site Positron Emission Tomography/Computed Tomography (PET/CT) imaging services and a new mobile Magnetic Resonance Imaging (MRI) program, bringing cutting-edge technology and greater convenience to local patients.
The PET/CT imaging, which will be available every Monday beginning Nov. 30, 2026, will bring one of the most advanced diagnostic tools in cancer care directly to residents of Chelsea and surrounding communities, allowing patients to receive sophisticated imaging services closer to home.
The new mobile MRI service will begin Dec. 1, 2026, expanding MRI availability to three days per week. The mobile unit will operate on Tuesdays, Thursdays and Fridays from 7 a.m. to 7 p.m., and provide capacity for up to 20 patients per day.
“These investments represent another important step in our commitment to addressing the health care needs of the communities we serve,” said Ben Miles, president of Chelsea Hospital. “For those facing a cancer diagnosis or another serious medical condition, access to advanced imaging close to home can make a significant difference. We are proud to offer this service locally, making it easier for patients to get the care they need.”
PET/CT combines two imaging technologies into one single exam. PET imaging reveals how tissues and organs are functioning at a cellular level, while CT imaging provides detailed anatomical information. Together, the technologies help physicians diagnose and determine the stage of cancer, develop treatment plans, monitor response to therapy and detect disease earlier than many other conventional imaging methods.
Exams will be performed by credentialed PET/CT technologists using an American College of Radiology (ACR)-accredited system. Results will be integrated into existing clinical workflows, ensuring seamless coordination among physicians and care teams.
“Expanding imaging services in this way will allow us to detect disease with greater precision, guide treatment decisions and monitor how our patients are responding to therapy,” said Fazle Mahmood, MD, FACP, FACR, chief medical officer of Chelsea Hospital. “Combined with our expanded MRI capacity, these services ensure patients have access to some of the most advanced imaging technology available, delivered by experienced teams dedicated to providing exceptional care.”
About Chelsea Hospital
Chelsea Hospital is a not-for-profit joint venture hospital, whose partners are Trinity Health Michigan, a Catholic health care system, and Michigan Medicine, the academic medical center of the University of Michigan. Founded in 1970, Chelsea Hospital is nationally recognized for both quality of care and patient satisfaction by national ranking organization Press Ganey, and is accredited by the Joint Commission. Chelsea Hospital employs more than 1,200 individuals with a medical staff of approximately 800 physicians. Key services include robust medical and surgical service lines, eight operating rooms, a 24-hour emergency department and senior emergency room, a state-of-the-art cancer center and a physical medicine and rehabilitation department. For additional information about Chelsea Hospital, please visit www.trinityhealthmichigan.org.
As members of Trinity Health, our services are connected to the national network of one of the largest health systems in the country. That means more access to experts, research, facilities, support, clinical trials and leading technology.
###


